TYK2 inhibition attenuates the stimulation of sensory neurons with hyper-IL-6

被引：0
|
作者：
Pritchard, T. [1 ]
Meng, M. [1 ]
Higham, J. [1 ]
Bulmer, D. [2 ]
机构：
[1] Univ Cambridge, Pharmacol, Cambridge, England
[2] Univ Cambridge, Dept Pharmacol, Cambridge, England
来源：
JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P176
引用
收藏
页码：I477 / I477
页数：1
相关论文
共 50 条
  • [1] Central TYK2 Inhibition Identifies TYK2 as a Key Neuroimmune Modulator
    Molitor, Tyler
    Hayashi, Genki
    Lin, Mei-Yao
    Dunn, Carissa
    Peterson, Nathan
    Poston, Robert
    Kurnellas, Michael
    Traver, David
    Patel, Seona
    Akgungor, Zeynep
    Leonardi, Virginia
    Lewis, Colizel
    Segales, Joshua
    Wood, Steve
    Rassoulpour, Arash
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 611 - 611
  • [2] Immunoadhesions of IL-6 and hyper-IL-6
    Jostock, T
    Blinn, G
    Renne, C
    Kallen, KJ
    Rose-John, S
    Ilberg, JM
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 413 - 413
  • [3] The hyper IgE syndrome and mutations in TYK2
    Woellner, Cristina
    Schaeffer, Alejandro A.
    Pluck, Jennifer M.
    Renner, Eleonore D.
    Knebel, Constanze
    Holland, Steve M.
    Plebani, Alessandro
    Grimbacher, Bodo
    IMMUNITY, 2007, 26 (05) : 535 - 535
  • [4] TYK2 inhibition halts SpA
    Sarah Onuora
    Nature Reviews Rheumatology, 2020, 16 : 248 - 248
  • [5] TYK2 inhibition halts SpA
    Onuora, Sarah
    NATURE REVIEWS RHEUMATOLOGY, 2020, 16 (05) : 248 - 248
  • [6] TYK2 inhibition shows promise
    Villanueva, M. Teresa
    NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (09) : 668 - 668
  • [7] Response:: The hyper IgE and mutations syndrome in TYK2
    Minegishi, Yoshiyuki
    Saito, Masako
    Karasuyama, Hajime
    IMMUNITY, 2007, 26 (05) : 536 - 536
  • [8] Hyper-IL-6: a potent and efficacious stimulator of RGC regeneration
    Fischer, D.
    EYE, 2017, 31 (02) : 173 - 178
  • [9] TYK2 inhibition: changing the treatment landscape for psoriasis?
    Abduelmula, Abrahim
    Gooderham, Melinda J.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (03) : 185 - 187
  • [10] DRUG DEVELOPMENT Esker launches for TYK2 inhibition
    Cross, Ryan
    CHEMICAL & ENGINEERING NEWS, 2021, 99 (17) : 13 - 13
12345